A rating of 100 puts GlycoMimetics Inc (GLYC) near the top of the Biotechnology industry according to InvestorsObserver. GlycoMimetics Inc's score of 100 means it scores higher than 100% of stocks in the industry. GlycoMimetics Inc also received an overall rating of 90, putting it above 90% of all stocks. Biotechnology is ranked 54 out of the 148 industries.
GLYC has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on GLYC!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 90 would rank higher than 90 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With GlycoMimetics Inc Stock Today?
GlycoMimetics Inc (GLYC) stock is up 1.95% while the S&P 500 has fallen -1.65% as of 3:05 PM on Monday, Nov 28. GLYC is up $0.04 from the previous closing price of $2.05 on volume of 355,631 shares. Over the past year the S&P 500 is down -14.94% while GLYC is up 21.51%. GLYC lost -$1.03 per share the over the last 12 months.
Click Here to get the full Stock Report for GlycoMimetics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
